Beneficient
BENF · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | -$3 | $0 | -$31 | $4 |
| % Growth | -1,495.5% | 100.6% | -801.1% | – |
| Cost of Goods Sold | $8 | $0 | $3 | $3 |
| Gross Profit | -$3 | -$0 | -$31 | $4 |
| % Margin | 100% | -22.2% | 100% | 100% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $5 | $8 | $5 | $5 |
| SG&A Expenses | $8 | $11 | $7 | $8 |
| Sales & Mktg Exp. | $2 | $3 | $2 | $3 |
| Other Operating Expenses | $7 | $69 | $4 | $6 |
| Operating Expenses | $15 | $80 | $11 | $14 |
| Operating Income | -$18 | -$26 | -$45 | -$10 |
| % Margin | 646.5% | -13,334.3% | 146.3% | -215.4% |
| Other Income/Exp. Net | $0 | -$66 | $0 | $0 |
| Pre-Tax Income | -$18 | -$93 | -$45 | -$10 |
| Tax Expense | $0 | $0 | -$1 | $1 |
| Net Income | -$4 | -$65 | -$1 | -$9 |
| % Margin | 131.3% | -32,866.7% | 2.5% | -195.6% |
| EPS | -3 | -57.55 | -0.091 | -1.32 |
| % Growth | 94.8% | -63,211.3% | 93.1% | – |
| EPS Diluted | -3 | -57.55 | -0.091 | -1.32 |
| Weighted Avg Shares Out | 1 | 1 | 9 | 7 |
| Weighted Avg Shares Out Dil | 1 | 1 | 9 | 7 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $5 | $3 | $3 | $3 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$13 | -$26 | -$42 | -$6 |
| % Margin | 464.1% | -13,212.1% | 134.9% | -131.9% |